Company Profile
Conserv Bioscience Limited
12930143•Private Limited With Share Capital
Get Full Access
05/10/2020
5 years
2
7
21200
very low risk
Company Overview
Registration, classification & business activity
Conserv Bioscience Limited (12930143) is a private limited with share capital incorporated on 05/10/2020 (5 years old) and registered in london, W1T6EB. The company operates under SIC code 21200 - manufacture of pharmaceutical preparations.
Conserv is a late-stage vaccine development company focused on advancing safe and effective vaccines that protect against endemic and emergent infectious diseases. we have a pipeline of eight vaccines in pre-clinical and clinical development including broad-spectrum influenza*, broad-spectrum corona...
Financial Overview
£270.6K
£27.2K
£243.4K
£4.52M
£0
Key Metrics
7
Employees
2
Directors
2
Shareholders
Charges
1
Registered
0
Outstanding
0
Part Satisfied
1
Satisfied
Filed Documents
Innovate Grants
This company received a grant of £415262.0 for Pan-Coronavirus Vaccine. The project started on 01/04/2022 and ended on 31/03/2023.
This company received a grant of £266523.0 for Development And Characterization Of A Pan-Flavivirus Vaccine Candidate. The project started on 01/01/2024 and ended on 31/12/2027.
+2 more grants available
Import / Export
Risk Assessment
very low risk
International Score
Future Factor
good
Performance Rating